The efficacy of fibrinogen concentrate compared with cryoprecipitate in major obstetric haemorrhage - an observational study.

Thumbnail
Name:
FibCryoPaperJune2012.pdf
Size:
487.2Kb
Format:
PDF
Download
Thumbnail
Name:
Table1Final.pdf
Size:
52.71Kb
Format:
PDF
Download
Thumbnail
Name:
Table2Final.pdf
Size:
46.43Kb
Format:
PDF
Download
Thumbnail
Name:
Table3Final.pdf
Size:
44.69Kb
Format:
PDF
Download
Thumbnail
Name:
Table4Final.pdf
Size:
47.71Kb
Format:
PDF
Download
View more files
Authors
Ahmed, S
Harrity, C
Johnson, S
Varadkar, S
McMorrow, S
Fanning, R
Flynn, C M
O' Riordan, J M
Byrne, B M
Affiliation
Department of Obstetrics and Gynaecology, Coombe Women and Infants University Hospital, Dublin, Ireland.
Issue Date
2012-10
MeSH
Adult
Blood Loss, Surgical
Coagulants
Delivery, Obstetric
Factor VIII
Female
Fibrinogen
Hemorrhage
Humans
Ireland

Metadata
Show full item record
Citation
The efficacy of fibrinogen concentrate compared with cryoprecipitate in major obstetric haemorrhage--an observational study. 2012, 22 (5):344-9 Transfus Med
Journal
Transfusion medicine (Oxford, England)
URI
http://hdl.handle.net/10147/269761
DOI
10.1111/j.1365-3148.2012.01178.x
PubMed ID
22994449
Abstract
Fibrinogen replacement is critical in major obstetric haemorrhage (MOH). Purified, pasteurised fibrinogen concentrate appears to have benefit over cryoprecipitate in ease of administration and safety but is unlicensed in pregnancy. In July 2009, the Irish Blood Transfusion Service replaced cryoprecipitate with fibrinogen.
Item Type
Article
Language
en
ISSN
1365-3148
Collections